JP7766946B2 - ムスカリン性アセチルコリン受容体ｍ４の陽性アロステリック調節因子としての７－（ピペリジン－１－イル）－４ｈ－ピリミド［１，２－ｂ］ピリダジン－４－オン誘導体 - Google Patents

ムスカリン性アセチルコリン受容体ｍ４の陽性アロステリック調節因子としての７－（ピペリジン－１－イル）－４ｈ－ピリミド［１，２－ｂ］ピリダジン－４－オン誘導体

Info

Publication number
JP7766946B2
JP7766946B2 JP2023502593A JP2023502593A JP7766946B2 JP 7766946 B2 JP7766946 B2 JP 7766946B2 JP 2023502593 A JP2023502593 A JP 2023502593A JP 2023502593 A JP2023502593 A JP 2023502593A JP 7766946 B2 JP7766946 B2 JP 7766946B2
Authority
JP
Japan
Prior art keywords
pyridazin
pyrimido
oxy
dihydrobenzo
dioxin
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
JP2023502593A
Other languages
English (en)
Japanese (ja)
Other versions
JP2023534803A5 (https=
JP2023534803A (ja
JPWO2022015988A5 (https=
Inventor
ダブリュ． リンズレイ，クレイグ
コン，ピー．ジェフリー
ダブリュ． エンガーズ，ダレン
アール． グレグロ，アリソン
ジェイ． テンプル，ケイラ
エフ． ロング，マデリーン
イー． リングイッテ，アンナ
エー． ベーカー，ローガン
ジェンセン，トーマス
Original Assignee
ヴァンダービルト ユニヴァーシティ
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by ヴァンダービルト ユニヴァーシティ filed Critical ヴァンダービルト ユニヴァーシティ
Publication of JP2023534803A publication Critical patent/JP2023534803A/ja
Publication of JP2023534803A5 publication Critical patent/JP2023534803A5/ja
Publication of JPWO2022015988A5 publication Critical patent/JPWO2022015988A5/ja
Application granted granted Critical
Publication of JP7766946B2 publication Critical patent/JP7766946B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D487/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00
    • C07D487/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, not provided for by groups C07D451/00 - C07D477/00 in which the condensed system contains two hetero rings
    • C07D487/04—Ortho-condensed systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Neurosurgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Neurology (AREA)
  • Biomedical Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Epidemiology (AREA)
JP2023502593A 2020-07-15 2021-07-15 ムスカリン性アセチルコリン受容体ｍ４の陽性アロステリック調節因子としての７－（ピペリジン－１－イル）－４ｈ－ピリミド［１，２－ｂ］ピリダジン－４－オン誘導体 Active JP7766946B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US202063052085P 2020-07-15 2020-07-15
US63/052,085 2020-07-15
PCT/US2021/041836 WO2022015988A1 (en) 2020-07-15 2021-07-15 7-(piperidin-1-yl)-4h-pyrimido[1,2-b]pyridazin-4-one derivatives as positive allosteric modulators of the muscarinic acetylcholine receptor m4

Publications (4)

Publication Number Publication Date
JP2023534803A JP2023534803A (ja) 2023-08-14
JP2023534803A5 JP2023534803A5 (https=) 2024-07-17
JPWO2022015988A5 JPWO2022015988A5 (https=) 2024-07-17
JP7766946B2 true JP7766946B2 (ja) 2025-11-11

Family

ID=77051222

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2023502593A Active JP7766946B2 (ja) 2020-07-15 2021-07-15 ムスカリン性アセチルコリン受容体ｍ４の陽性アロステリック調節因子としての７－（ピペリジン－１－イル）－４ｈ－ピリミド［１，２－ｂ］ピリダジン－４－オン誘導体

Country Status (11)

Country Link
US (3) US12331055B2 (https=)
EP (1) EP4182316A1 (https=)
JP (1) JP7766946B2 (https=)
KR (1) KR20230039701A (https=)
CN (1) CN116209446B (https=)
AU (1) AU2021308625A1 (https=)
BR (1) BR112023000760A2 (https=)
CA (1) CA3189217A1 (https=)
IL (1) IL299758B2 (https=)
MX (1) MX2023000580A (https=)
WO (1) WO2022015988A1 (https=)

Families Citing this family (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4182316A1 (en) * 2020-07-15 2023-05-24 Vanderbilt University 7-(piperidin-1-yl)-4h-pyrimido[1,2-b]pyridazin-4-one derivatives as positive allosteric modulators of the muscarinic acetylcholine receptor m4
WO2023114224A1 (en) 2021-12-13 2023-06-22 Sage Therapeutics, Inc. Combination of muscarinic receptor positive modulators and nmda positive allosteric modulators
WO2023141511A1 (en) * 2022-01-19 2023-07-27 Vanderbilt University Positive allosteric modulators of the muscarinic acetylcholine receptor m4
EP4611127A4 (en) 2022-12-02 2025-12-31 Lg Energy Solution Ltd BATTERY BLOCK AND ITS MANUFACTURING PROCESS
AU2024259614A1 (en) 2023-04-18 2025-10-02 Vanderbilt University Thiazolopyridine derivatives as positive allosteric modulators of the muscarinic acetylcholine receptor m4
KR20260035912A (ko) * 2023-06-22 2026-03-13 반더빌트유니버시티 무스카린성 아세틸콜린 수용체 m4의 양성 조절제
WO2025122733A1 (en) 2023-12-07 2025-06-12 Neumora Therapeutics, Inc. Crystalline forms of 7-((2r,4s)-4-((2,3-dihydrobenzo[b][1,4] dioxin-6-yl-2,2,3,3-d4)oxy)-2-methylpiperidin-1-yl)-8-methyl-4h-pyrimido[1,2-b]pyridazin -4-one
WO2026047494A1 (en) 2024-08-26 2026-03-05 Suven Life Sciences Limited 2-AMINO-PYRIMIDINE DERIVATIVES AS MUSCARINIC M4 RECEPTOR POSITIVE ALLOSTERIC MODULATORS (M4 PAMs)

Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017107087A1 (en) 2015-12-23 2017-06-29 Merck Sharp & Dohme Corp. 6, 7-dihydro-5h-pyrrolo [3, 4-b] pyridin-5-oneallosteric modulators of the m4 muscarinic acetylcholine receptor
WO2018118735A1 (en) 2016-12-22 2018-06-28 Merck Sharp & Dohme Corp. 6,6-fused heteroaryl piperidine ether allosteric modulators of the m4 muscarinic acetylcholine receptor
WO2018118736A1 (en) 2016-12-22 2018-06-28 Merck Sharp & Dohme Corp. 6,5-fused heteroaryl piperidine ether allosteric modulators of the m4 muscarinic acetylcholine receptor
WO2018118734A1 (en) 2016-12-22 2018-06-28 Merck Sharp & Dohme Corp. Heteroaryl piperidine ether allosteric modulators of the m4 muscarinic acetylcholine receptor

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US9156833B2 (en) * 2012-07-16 2015-10-13 Barry University, Inc. Bitopic muscarinic agonists and antagonists and methods of synthesis and use thereof
WO2014122474A1 (en) 2013-02-07 2014-08-14 Takeda Pharmaceutical Company Limited Piperidin-1 -yl and azepin-1 -yl carboxylates as muscarinic m4 receptor agonists
US10329289B2 (en) * 2015-12-23 2019-06-25 Merck Sharp & Dohme Corp. 6,7-dihydro-5H-pyrrolo[3,4-B]pyridin-5-one allosteric modulators of the M4 muscarinic acetylcholine receptor
US10961253B2 (en) * 2016-11-07 2021-03-30 Vanderbilt University Positive allosteric modulators of the muscarinic acetylcholine receptor M4
WO2019000238A1 (en) * 2017-06-27 2019-01-03 Merck Sharp & Dohme Corp. 5- (PYRIDIN-3-YL) OXAZOLE ALLOSTERIC MODULATORS OF M4 ACETYLCHOLINE MUSCARINIC RECEPTOR
EP4182316A1 (en) * 2020-07-15 2023-05-24 Vanderbilt University 7-(piperidin-1-yl)-4h-pyrimido[1,2-b]pyridazin-4-one derivatives as positive allosteric modulators of the muscarinic acetylcholine receptor m4

Patent Citations (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2017107087A1 (en) 2015-12-23 2017-06-29 Merck Sharp & Dohme Corp. 6, 7-dihydro-5h-pyrrolo [3, 4-b] pyridin-5-oneallosteric modulators of the m4 muscarinic acetylcholine receptor
WO2018118735A1 (en) 2016-12-22 2018-06-28 Merck Sharp & Dohme Corp. 6,6-fused heteroaryl piperidine ether allosteric modulators of the m4 muscarinic acetylcholine receptor
WO2018118736A1 (en) 2016-12-22 2018-06-28 Merck Sharp & Dohme Corp. 6,5-fused heteroaryl piperidine ether allosteric modulators of the m4 muscarinic acetylcholine receptor
WO2018118734A1 (en) 2016-12-22 2018-06-28 Merck Sharp & Dohme Corp. Heteroaryl piperidine ether allosteric modulators of the m4 muscarinic acetylcholine receptor

Also Published As

Publication number Publication date
US11884676B2 (en) 2024-01-30
KR20230039701A (ko) 2023-03-21
US20230286991A1 (en) 2023-09-14
EP4182316A1 (en) 2023-05-24
JP2023534803A (ja) 2023-08-14
IL299758A (en) 2023-03-01
IL299758B2 (en) 2026-04-01
BR112023000760A2 (pt) 2023-02-07
US12331055B2 (en) 2025-06-17
US20250263417A1 (en) 2025-08-21
CN116209446A (zh) 2023-06-02
US20230257381A1 (en) 2023-08-17
IL299758B1 (en) 2025-12-01
WO2022015988A1 (en) 2022-01-20
MX2023000580A (es) 2023-02-13
AU2021308625A1 (en) 2023-02-09
CN116209446B (zh) 2025-05-13
CA3189217A1 (en) 2022-01-20

Similar Documents

Publication Publication Date Title
JP7766946B2 (ja) ムスカリン性アセチルコリン受容体ｍ４の陽性アロステリック調節因子としての７－（ピペリジン－１－イル）－４ｈ－ピリミド［１，２－ｂ］ピリダジン－４－オン誘導体
JP7270989B2 (ja) ムスカリン性アセチルコリン受容体ｍ４のアンタゴニスト
EP3534901B1 (en) Positive allosteric modulators of the muscarinic acetylcholine receptor m4
CA3068842A1 (en) Antagonists of the muscarinic acetylcholine receptor m4
WO2023064584A1 (en) 7,8-dihydro-5h-1,6-naphthyridine derivatives as positive allosteric modulators of the muscarinic acetylcholine receptor m4 for treating neurological and psychiatric disorders
CA3163933A1 (en) Antagonists of the muscarinic acetylcholine receptor m4
EP3558309B1 (en) Positive allosteric modulators of the muscarinic acetylcholine receptor m4
EP4267569B1 (en) Antagonists of the muscarinic acetylcholine receptor m4
CA3180717A1 (en) Condensed substituted hydropyrroles as antagonists of the muscarinic acetylcholine receptor m4
KR20240112343A (ko) 무스카린성 아세틸콜린 수용체 m4의 길항제
JP2023549534A (ja) ムスカリン性アセチルコリン受容体ｍ４のアンタゴニスト
JP2023506741A (ja) ムスカリン性アセチルコリン受容体ｍ４のアンタゴニスト
US20250026752A1 (en) Positive allosteric modulators of the muscarinic acetylcholine receptor m4
WO2023141511A1 (en) Positive allosteric modulators of the muscarinic acetylcholine receptor m4
ES2991955T3 (es) Antagonistas del receptor muscarínico de la acetilcolina M4
WO2022261427A1 (en) (4-(6-((2-octahydrocyclopenta[c]pyrrol-5-yl)amino)pyridazin-3-yl)phenyl)(imino)(methyl)-lambda6- sulfanone derivatives and similar compounds as muscarinic acetylcholine receptor m4 antagonists for the treatment of neurodegenerative disorders
EP3720859A1 (en) Positive allosteric modulators of the muscarinic acetylcholine receptor m4
WO2020086864A1 (en) Positive allosteric modulators of the muscarinic acetylcholine receptor m1
HK40014595B (en) Positive allosteric modulators of the muscarinic acetylcholine receptor m4
HK40014595A (en) Positive allosteric modulators of the muscarinic acetylcholine receptor m4

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20240708

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20240708

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20250422

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20250424

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20250722

TRDD Decision of grant or rejection written
A01 Written decision to grant a patent or to grant a registration (utility model)

Free format text: JAPANESE INTERMEDIATE CODE: A01

Effective date: 20251007

A61 First payment of annual fees (during grant procedure)

Free format text: JAPANESE INTERMEDIATE CODE: A61

Effective date: 20251022

R150 Certificate of patent or registration of utility model

Ref document number: 7766946

Country of ref document: JP

Free format text: JAPANESE INTERMEDIATE CODE: R150